Hide/Show Apps

Actin stabilizing compounds show specific biological effects due to their binding mode

2019-07-05
Wang, Shuaijun
Crevenna, Alvaro H.
Ugur, Ilke
Marıon, Antoıne
Antes, Iris
Kazmaier, Uli
Hoyer, Maria
Lamb, Don C.
Gegenfurtner, Florian
Kliesmetes, Zane
Ziegenhain, Christoph
Enard, Wolfgang
Vollmar, Angelika
Zahler, Stefan
Actin binding compounds are widely used tools in cell biology. We compare the biological and biochemical effects of miuraenamide A and jasplakinolide, a structurally related prototypic actin stabilizer. Though both compounds have similar effects on cytoskeletal morphology and proliferation, they affect migration and transcription in a distinctive manner, as shown by a transcriptome approach in endothelial cells. In vitro, miuraenamide A acts as an actin nucleating, F-actin polymerizing and stabilizing compound, just like described for jasplakinolide. However, in contrast to jasplakinolide, miuraenamide A competes with cofilin, but not gelsolin or Arp2/3 for binding to F-actin. We propose a binding mode of miuraenamide A, explaining both its similarities and its differences to jasplakinolide. Molecular dynamics simulations suggest that the bromophenol group of miurenamide A interacts with residues Tyr133, Tyr143, and Phe352 of actin. This shifts the D-loop of the neighboring actin, creating tighter packing of the monomers, and occluding the binding site of cofilin. Since relatively small changes in the molecular structure give rise to this selectivity, actin binding compounds surprisingly are promising scaffolds for creating actin binders with specific functionality instead of just "stabilizers".